Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial
| Date first appeared online | 10/07/2024 |
| DOI | 10.1007/s00125-024-06142-3 |
| Authors | Bain S. |
| Journal Name | Diabetologia |
| Volume | 67 |
Documents
- 67735.VOR.pdf , Book, © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License (CC-BY 4.0).